ClinicalTrials.Veeva

Menu

Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Drug Induced Liver Injury

Study type

Observational

Funder types

Other

Identifiers

NCT01000766
50KR10957

Details and patient eligibility

About

The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver.

Full description

Our hypothesis is that there are liver-specific particles, called mRNA, that are identifiable in a person's blood sample during liver injury caused by some drugs. The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver, perhaps early in the process before significant injury or illness have occurred.

Enrollment

25 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • ALT > 200 IU/L at presentation to UNC Hospitals
  • Drug induced liver injury considered likely by admitting medical staff

Trial design

25 participants in 1 patient group

Acute drug-induced liver injury

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems